Success Metrics

Clinical Success Rate
90.9%

Based on 10 completed trials

Completion Rate
91%(10/11)
Active Trials
0(0%)
Results Posted
20%(2 trials)
Terminated
1(6%)

Phase Distribution

Ph phase_1
3
19%
Ph phase_2
1
6%
Ph phase_4
1
6%
Ph not_applicable
10
63%
Ph phase_3
1
6%

Phase Distribution

3

Early Stage

1

Mid Stage

2

Late Stage

Phase Distribution16 total trials
Phase 1Safety & dosage
3(18.8%)
Phase 2Efficacy & side effects
1(6.3%)
Phase 3Large-scale testing
1(6.3%)
Phase 4Post-market surveillance
1(6.3%)
N/ANon-phased studies
10(62.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

90.9%

10 of 11 finished

Non-Completion Rate

9.1%

1 ended early

Currently Active

0

trials recruiting

Total Trials

16

all time

Status Distribution
Active(1)
Completed(10)
Terminated(1)
Other(4)

Detailed Status

Completed10
unknown4
Terminated1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
16
Active
0
Success Rate
90.9%
Most Advanced
Phase 4

Trials by Phase

Phase 13 (18.8%)
Phase 21 (6.3%)
Phase 31 (6.3%)
Phase 41 (6.3%)
N/A10 (62.5%)

Trials by Status

unknown425%
completed1063%
terminated16%
not_yet_recruiting16%

Recent Activity

0 active trials
Showing 5 of 16
not_yet_recruitingnot_applicable

Algal Lutein Against Decline of Intellectual Nimbleness

NCT07600567
unknownnot_applicable

Lutein Supplementation in Healthy Children

NCT05314647
completednot_applicable

Randomized Controlled Trial of LUtein as a Novel Neuroprotective Adjunctive Therapy to Improve Visual Outcome of Rhegmatogenous Retinal Detachment (LUNAR Study)

NCT03932305
completednot_applicable

Feeding Trial to Determine How Combinations of Different Dietary Bioactive Ingredients Influence High Density Lipoprotein (HDL) Metabolism

NCT01803594
unknownnot_applicable

Effects of Lutein Supplementation on Cognition and MPOD in Multiple Sclerosis Patients-

NCT04843813
View all 16 trials

Clinical Trials (16)

Showing 16 of 16 trials
NCT07600567Not Applicable

Algal Lutein Against Decline of Intellectual Nimbleness

Not Yet Recruiting
NCT05314647Not Applicable

Lutein Supplementation in Healthy Children

Unknown
NCT03932305Not Applicable

Randomized Controlled Trial of LUtein as a Novel Neuroprotective Adjunctive Therapy to Improve Visual Outcome of Rhegmatogenous Retinal Detachment (LUNAR Study)

Completed
NCT01803594Not Applicable

Feeding Trial to Determine How Combinations of Different Dietary Bioactive Ingredients Influence High Density Lipoprotein (HDL) Metabolism

Completed
NCT04843813Not Applicable

Effects of Lutein Supplementation on Cognition and MPOD in Multiple Sclerosis Patients-

Unknown
NCT03113864Not Applicable

Effects of Lutein on Visual Function

Terminated
NCT00527553Not Applicable

The Effect of Eggs and Egg Products on Macular Pigment

Completed
NCT00121589Phase 1

Lutein/Zeaxanthin and Omega-3 Supplementation in Persons Over Age 60

Completed
NCT00346333Phase 3

Clinical Trial of Lutein for Patients With Retinitis Pigmentosa Receiving Vitamin A

Completed
NCT01056094Phase 1

Effects of Lutein Supplementation on Oxidative Stress and Inflammation in Healthy Nonsmokers

Unknown
NCT00564902Not Applicable

The Zeaxanthin and Visual Function Study

Completed
NCT01048476Phase 1

Effects of Lutein and Zeaxanthin Supplementation on Age-related Macular Degeneration

Unknown
NCT00449917Phase 4

"Visiobiane Anti-age" Effects on Vision Parameters

Completed
NCT01042860Not Applicable

The Influence of Lutein Supplements on Age-related Macular Degeneration

Completed
NCT00718653Not Applicable

Effects of Antioxidants on Human Macular Pigments

Completed
NCT00006202Phase 2

Lutein for Age-Related Macular Degeneration

Completed

All 16 trials loaded

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
16